Jonathan Yingling
Director Técnico/Científico/I+D en ARCUS BIOSCIENCES, INC. .
Cargos activos de Jonathan Yingling
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ARCUS BIOSCIENCES, INC. | Director Técnico/Científico/I+D | 01/01/2020 | - |
Historial de carrera de Jonathan Yingling
Antiguos cargos conocidos de Jonathan Yingling.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Director Técnico/Científico/I+D | 01/01/2018 | 31/01/2020 |
| Corporate Officer/Principal | 06/02/2017 | 01/01/2018 | |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/06/2013 | 01/10/2015 |
| DNIB UNWIND INC | Director Técnico/Científico/I+D | 16/12/2015 | - |
Formación de Jonathan Yingling.
| Duke University School of Medicine | Doctorate Degree |
| The College of William & Mary | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
Operativa
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ARCUS BIOSCIENCES, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Jonathan Yingling
- Experiencia